OFM
KMTS

Omega Fund Management’s Kestra Medical Technologies KMTS Stock Holding History

Omega Fund Management’s Portfolio KMTS Stock Details KMTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$26M Hold
1,022,149
– – 14% 3
2026
Q1 		$20.4M Sell
1,022,149
-351,442
-26% -$8.28M 12.49% 4
2025
Q4 		$36.4M Sell
1,373,591
-272,302
-17% -$7.01M 12.71% 5
2025
Q3 		$39.1M Hold
1,645,893
– – 17.59% 1
2025
Q2 		$27.3M Sell
1,645,893
-150,000
-8% -$3.27M 17.67% 2
2025
Q1 		$44.8M Buy
+1,795,893
New +$41.3M 26.41% 1

Other funds holding KMTS

BCI
Bain Capital Investors Boston, Massachusetts $4.82B AUM 35.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AP
Andera Partners Paris $206M AUM
YF
Yu Fan $108M AUM 137.54% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Omega Fund Management's KMTS Position: Q2 2026 in Review

Omega Fund Management held its Kestra Medical Technologies (KMTS) position steady in Q2 2026 at 1,022,149 shares worth $26M. The position accounts for 14% of the portfolio, ranked #3.

Omega Fund Management first reported a position in KMTS in Q1 2025 and has held it in 6 quarters since. The position peaked at $44.8M in Q1 2025. 109 funds tracked by Wall St. Rank hold KMTS as of Q2 2026.

  • Omega Fund Management held 1,022,149 shares of Kestra Medical Technologies worth $26M as of Q2 2026.
  • Omega Fund Management left its Kestra Medical Technologies share count unchanged in Q2 2026.
  • Kestra Medical Technologies made up 14% of Omega Fund Management's portfolio in Q2 2026, its #3 holding.
  • Omega Fund Management first reported a position in Kestra Medical Technologies in Q1 2025 and has held it in 6 quarters since.
  • Omega Fund Management's Kestra Medical Technologies position peaked at $44.8M in Q1 2025.
  • 109 funds tracked by Wall St. Rank held Kestra Medical Technologies as of Q2 2026.

Based on Omega Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.